Medicaid Member Use Of MOUD Increases to 69% 

Among Medicaid beneficiaries with opioid use disorder (OUD), medication-assisted treatment rose from 60.0% in 2018 to 69.1% in 2023. Although uptake of medications for opioid use disorder (MOUD) increased, treatment continuation for at least 180 days declined, falling from 62.6% to 57.7%.

Between 2018 and 2023, federal and state governments rolled out many policies and programs to increase use of MOUD. These included expanding coverage for MOUD under state Medicaid programs, easing burdens for clinical professionals to prescribe buprenorphine, easing restrictions on take-home methadone doses, making telehealth access to MOUD prescriptions easier, and requiring . . .